CBP-CON-00173
Active
Federal
CSL BEHRING (AUSTRALIA) PTY LTD
Awarded by National Blood Authority
National Blood Authority engaged CSL BEHRING (AUSTRALIA) PTY LTD to supply imported plasma and recombinant products (Factor XI Concentrate) under a limited-tender contract valued at AU$8,324,384 from September 2022 to June 2027. The exemption cited exclusive rights or proprietary information with no reasonable alternative supplier. The contract has one amendment.
$8.3M
Contract Value
Contract Details
- Reference
- CN3924656
- Jurisdiction
- Federal
- Financial Year
- FY27
- Category
- Healthcare Services(UNSPSC: 85100000)
Description
Imported Plasma and Recombinant Products (Factor XI Concentrate)
Key Dates
- Publish Date
- 16 July 2026
- Effective Date
- 30 Sept 2022
- End Date
- 29 June 2027
Published fields
- Procurement method
- Limited tender
- Location
- Not published in this source
Supplier
CSL BEHRING (AUSTRALIA) PTY LTD
- ABN
- 48 160 734 761
Agency
National Blood Authority
- ABN
- 87 361 602 478
Contract History
This contract has been amended 1 time.
Original Contract
Published 2 Nov 2022
$7.6M
Amendment A1
Current
Published 16 July 2026
$8.3M